Jovanović, M.Z.; Jurišević, M.; Jovanović, M.; Gajović, N.; Jocić, M.; Jovanović, M.M.; Milev, B.; Vasiljev, K.D.; Jovanović, I.
Co-Targeting PD-1 and IL-33/ST2 Pathways for Enhanced Acquired Anti-Tumor Immunity in Breast Cancer. Int. J. Mol. Sci. 2025, 26, 9600.
https://doi.org/10.3390/ijms26199600
AMA Style
Jovanović MZ, Jurišević M, Jovanović M, Gajović N, Jocić M, Jovanović MM, Milev B, Vasiljev KD, Jovanović I.
Co-Targeting PD-1 and IL-33/ST2 Pathways for Enhanced Acquired Anti-Tumor Immunity in Breast Cancer. International Journal of Molecular Sciences. 2025; 26(19):9600.
https://doi.org/10.3390/ijms26199600
Chicago/Turabian Style
Jovanović, Marina Z., Milena Jurišević, Milan Jovanović, Nevena Gajović, Miodrag Jocić, Marina M. Jovanović, Boško Milev, Krstina Doklestić Vasiljev, and Ivan Jovanović.
2025. "Co-Targeting PD-1 and IL-33/ST2 Pathways for Enhanced Acquired Anti-Tumor Immunity in Breast Cancer" International Journal of Molecular Sciences 26, no. 19: 9600.
https://doi.org/10.3390/ijms26199600
APA Style
Jovanović, M. Z., Jurišević, M., Jovanović, M., Gajović, N., Jocić, M., Jovanović, M. M., Milev, B., Vasiljev, K. D., & Jovanović, I.
(2025). Co-Targeting PD-1 and IL-33/ST2 Pathways for Enhanced Acquired Anti-Tumor Immunity in Breast Cancer. International Journal of Molecular Sciences, 26(19), 9600.
https://doi.org/10.3390/ijms26199600
